← 返回

Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.

Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.

期刊: Interventional cardiology clinics 日期: 2026-10-01 PMID: 42648863 DOI: 10.1016/j.iccl.2026.05.005 浏览: 7
作者: Proshkina A, Ghanem F, Al Turk A
A, P., F, G., & A, A.T. (2026). Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.. Interventional cardiology clinics. https://doi.org/10.1016/j.iccl.2026.05.005
A P, F G, A AT. Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.. Interventional cardiology clinics. 2026; doi: 10.1016/j.iccl.2026.05.005
A P, F G, A AT. Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.[J]. Interventional cardiology clinics. 2026. DOI: 10.1016/j.iccl.2026.05.005.
@article{a2026,
  author = {Proshkina A and Ghanem F and Al Turk A},
  title = {Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.},
  journal = {Interventional cardiology clinics},
  year = {2026},
  doi = {10.1016/j.iccl.2026.05.005},
  note = {PMID: 42648863},
}
TY  - JOUR
AU  - Proshkina A
AU  - Ghanem F
AU  - Al Turk A
TI  - Valve-In-Valve Transcatheter Aortic Valve Replacement: Advances in Planning, Technique, and Lifetime Management.
T2  - Interventional cardiology clinics
PY  - 2026
DO  - 10.1016/j.iccl.2026.05.005
AN  - PMID:42648863
ER  - 

摘要

Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) has emerged as a key reintervention strategy for failed surgical bioprostheses. Meticulous preprocedural planning with computed tomography, fluoroscopy, and transesophageal echocardiography is essential for optimal outcomes. Emerging artificial intelligence-based technologies may help mitigate associated risks such as coronary obstruction and patient-prosthesis mismatch and assist with lifetime management planning for valvular heart disease. Transcatheter valve underexpansion can be addressed through bioprosthetic valve fracture in select cases. ViV-TAVR is likely to continue to grow in prevalence given an aging population, its minimally invasive nature compared to redo surgical aortic valve replacement, and its favorable safety profile.

AI 智能解读

相关文献

返回分类: 心血管 查看原文 (DOI)
已选择 0 篇文献